Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Nov. 30, 2018	Nov. 30, 2017	Nov. 30, 2016
Operating activities
Net income	$ 933.4	$ 477.4	$ 472.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	150.7	125.2	108.7
Stock-based compensation	25.6	23.9	25.6
Noncash income tax benefit (related to enactment of the U.S. Tax Act)	(309.4)	0.0	0.0
Special charges and transaction and integration expenses	3.0	19.1	7.2
Amortization of inventory fair value adjustment associated with acquisition of RB Foods	0.0	20.9	0.0
(Gain) loss on sale of assets	(5.4)	1.3	1.5
Deferred income tax expense (benefit)	40.1	24.1	(40.0)
Income from unconsolidated operations	(34.8)	(33.9)	(36.1)
Settlement of forward-starting interest rate swaps	0.0	(2.9)	0.0
Changes in operating assets and liabilities (net of effect of businesses acquired):
Trade accounts receivable	19.8	(13.0)	(21.0)
Inventories	(10.0)	44.6	(39.0)
Trade accounts payable	72.8	98.2	47.0
Other assets and liabilities	(91.8)	6.8	94.5
Dividends received from unconsolidated affiliates	27.2	23.6	37.4
Net cash provided by operating activities	821.2	815.3	658.1
Investing activities
Acquisitions of businesses (net of cash acquired)	(4.2)	(4,327.4)	(120.6)
Proceeds from exit of consolidated joint venture (net of cash paid of $0.9)	0.0	0.0	4.2
Capital expenditures	(169.1)	(182.4)	(153.8)
Proceeds from sale of property, plant and equipment	12.3	1.1	1.7
Proceeds from insurance	2.5	0.4	1.4
Net cash used in investing activities	(158.5)	(4,508.3)	(267.1)
Financing activities
Short-term borrowings, net	305.5	(134.6)	251.7
Long-term debt borrowings	25.9	3,989.6	6.0
Payment of debt issuance costs	0.0	(7.7)	0.0
Long-term debt repayments	(797.9)	(272.7)	(202.0)
Proceeds from exercised stock options	78.2	29.5	36.8
Taxes withheld and paid on employee stock awards	(11.6)	(5.8)	(3.5)
Payment of contingent consideration	(2.5)	(19.7)	0.0
Purchase of minority interest	(13.0)	(1.2)	0.0
Issuance of common stock non-voting (net of issuance costs of $0.9)	0.0	554.0	0.0
Common stock acquired by purchase	(62.3)	(137.8)	(242.7)
Dividends paid	(273.4)	(237.6)	(217.8)
Net cash provided by (used in) financing activities	(751.1)	3,756.0	(371.5)
Effect of exchange rate changes on cash and cash equivalents	(1.8)	5.4	(13.7)
(Decrease) increase in cash and cash equivalents	(90.2)	68.4	5.8
Cash and cash equivalents at beginning of year	186.8	118.4	112.6
Cash and cash equivalents at end of year	$ 96.6	$ 186.8	$ 118.4